a public good project by the
Synthesis
Company
of California

© 2026

Marco Chinol | doi.page

0 works0 citations0 h-index

Marco Chinol

European Institute of Oncology(IT)

Publications by Year

Research Areas

Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Medical Imaging Techniques and Applications, Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies

Most-Cited Works

→ Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study(2011)417 cited
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.(2005)
→ Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study(2003)304 cited
→ Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours(2004)223 cited
→ Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin(1999)214 cited
→ Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide(2001)205 cited
→ Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study(2002)167 cited

→ Biokinetics and dosimetry in patients administered with 111 In-DOTA-Tyr 3 -octreotide: implications for internal radiotherapy with 90 Y-DOTATOC(1999)151 cited

→ Pre-Targeted Locoregional Radioimmunotherapy with 90 Y-biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic Results(2001)130 cited

→ Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide: The experience of the european institute of oncology group(2002)127 cited